What is the workup for microcytic, normochromic anemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The workup of microcytic, normochromic anemia should begin with a complete blood count (CBC) with peripheral smear, iron studies (serum iron, total iron binding capacity, ferritin), and hemoglobin electrophoresis, as recommended by the most recent guidelines 1.

Initial Evaluation

The initial evaluation of microcytic, normochromic anemia should include:

  • Serum ferritin, which is the most specific test for iron deficiency in the absence of inflammation, with a level of <15 μg/L being indicative of absent iron stores 1
  • Transferrin saturation, which can help distinguish between iron deficiency and other causes of microcytic anemia
  • Reticulocyte count, which can help assess the severity of anemia and guide further testing
  • Comprehensive metabolic panel to assess liver and kidney function

Further Testing

If iron deficiency is suspected, further testing may include:

  • Stool for occult blood to identify potential sources of bleeding, especially in adults
  • Upper and lower endoscopy to identify potential sources of bleeding
  • Lead levels, particularly in children, to rule out lead poisoning as a cause of microcytic anemia
  • Inflammatory markers like C-reactive protein and erythrocyte sedimentation rate to assess for anemia of chronic disease
  • Bone marrow examination in some cases to rule out other causes of microcytic anemia

Diagnosis and Treatment

The diagnosis and treatment of microcytic, normochromic anemia depend on the underlying cause.

  • Iron supplementation (typically ferrous sulfate 325mg three times daily) for iron deficiency 1
  • Addressing chronic diseases for anemia of chronic inflammation
  • Specific management for thalassemia, such as blood transfusions and iron chelation therapy It is essential to note that the distinction between microcytic normochromic and microcytic hypochromic anemia is crucial, as normochromic presentation may suggest early iron deficiency, thalassemia trait, or anemia of chronic disease rather than classic iron deficiency which typically presents as hypochromic 1.

From the Research

Workup of Microcytic Anemia

The workup of microcytic anemia involves several steps to determine the underlying cause of the condition.

  • The laboratory evaluation of anemia begins with a complete blood count and reticulocyte count, as stated in the study 2.
  • The anemia is then categorized as microcytic, macrocytic, or normocytic, with or without reticulocytosis.
  • Examination of the peripheral smear and a small number of specific tests confirm the diagnosis.

Diagnostic Tests

Several diagnostic tests are used to evaluate microcytic anemia, including:

  • Serum iron level
  • Total iron-binding capacity
  • Serum ferritin level
  • Hemoglobin electrophoresis, as mentioned in the study 2
  • Erythrocyte size-distribution width, which may be helpful in distinguishing iron deficiency from thalassemia minor, as stated in the study 2

Common Causes of Microcytic Anemia

The most common causes of microcytic anemia include:

  • Iron deficiency anemia, which can be managed with oral or intravenous iron, depending on the severity and comorbid conditions of the affected individual, as mentioned in the study 3
  • Thalassemia, a genetic disorder that affects the production of hemoglobin, as stated in the study 3
  • Sideroblastic anemia, a rare disorder characterized by the accumulation of iron in the mitochondria of red blood cells, as mentioned in the study 4

Evaluation of Conventional Laboratory Parameters

The evaluation of conventional laboratory parameters, such as hemoglobin, mean corpuscular volume (MCV), mean corpuscular hemoglobin concentration (MCHC), and mean corpuscular hemoglobin (MCH), can help differentiate between iron deficiency anemia and thalassemia, as stated in the study 5.

  • In patients with iron deficiency anemia, these parameters are typically lower than in those with thalassemia.
  • The red blood cell distribution width (RDW) may also be useful in discriminating between the different types of microcytic anemia, as mentioned in the study 5

Underuse of Laboratory Testing

The underuse of laboratory testing in the diagnostic workup of microcytic anemia is a significant issue, as highlighted in the study 6.

  • Follow-up testing for iron deficiency was not performed in 34% of cases, and testing for thalassemia was not performed in 55% of cases with suspected thalassemia.
  • The frequency of underuse of iron status and thalassemia/hemoglobinopathy testing decreased from group 1 to group 3, as stated in the study 6

Related Questions

Can someone develop microcytic anemia from blood donation?
What parameters should be included in a table for anemia labs?
What is the initial step in anemia workup and subsequent treatment?
What is the next step for a patient with severe microcytic anemia (low Mean Corpuscular Volume (MCV)) and a hemoglobin level indicating severe anemia?
Does a normal MCH and MCHC rule out microcytic anemia?
What antibiotics cover common organisms found in the New York City (NYC) metropolitan area for acute bacterial rhinosinusitis (ABRS)?
What is the possible diagnosis for a 42-year-old Caucasian female with a Mirena (levonorgestrel-releasing intrauterine system) in place, presenting with dyspareunia (painful intercourse) and hematuria (bright red, mucous blood) accompanied by a transient fecal odor, and a 4.9 cm ovarian cyst on the right ovary, with negative tests for trichomoniasis, gonorrhea, yeast infection, bacterial vaginosis (BV), syphilis, Human Immunodeficiency Virus (HIV), and Hepatitis C (Hep C)?
Is it safe to use celecoxib with methotrexate?
Should a patient with age-related osteoporosis and stable bone mineral density (BMD) on Vitamin D3 (Cholecalciferol) 50 mcg twice daily, with normal serum calcium and Vitamin D 25-hydroxy (25 OH) levels, and a C-terminal telopeptide (CTX) level within the normal pre-menopausal reference range, receive another infusion of Reclast (Zoledronic acid)?
What could be the explanation for dyspareunia with bright red, mucous blood, and transient fecal odor in a 42-year-old Caucasian female with a 4.9 cm ovarian cyst, Mirena (levonorgestrel) intrauterine device (IUD) in place, and negative screenings for trichomoniasis, gonorrhea, yeast, bacterial vaginosis (BV), syphilis, Human Immunodeficiency Virus (HIV), and Hepatitis C (Hep C)?
Can a nonunion fracture eventually achieve bone union after one year?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.